The steady state levels of c-myc mRNA have been measured in RNA samples extracted from colonoscopic biopsies of inflammatory bowel disease patients obtained at routine endoscopy sessions. Biopsies were immediately frozen in liquid nitrogen limiting the ischaemic time to less than 15 seconds, and can be stored for up to 96 hours before separation of RNA. Yields of RNA using biopsies were 0.137 (0.041)% wet wt (mean (SD), n=68), these are significantly better than those obtained from surgical material (0. 
Epithelial cells of the colonic mucosa in ulcerative colitis and Crohn's colitis in relapse show increased proliferation compared with quiescent disease, or with control patients.' This may reflect immunological damage to the colonic epithelial cells, which express HLA class II antigens in patients with active inflammatory bowel disease. 23 Although malignant change in Crohn's disease has been described,4 there is a far greater risk of colonic adenocarcinoma developing in patients with extensive longstanding ulcerative colitis. 5 Proto-oncogenes were initially described as the normal cellular homologues of the transforming determinants of oncogenic retroviruses.' These genes are normally intimately concerned with the control of cellular division and differentiation." There has been particular interest in the class of proto-oncogenes that code for DNA binding proteins which regulate gene transcription within the nucleus, as these may represent part of a final common pathway of cell cycle control. 7 The mRNAs of certain 'nuclear' protooncogenes including c-myc and c-fos increase rapidly but transiently in response to cellular stimulation by mitogens or growth factors8`; these are termed early response genes.
C-myc was originally described as the cellular homologue of the oncogene in the avian myelocytomatosis virus (v-myc).6 It codes for a nuclear protein'0 that dimerises and binds to DNA" through an amphipathic helix structure,'2 and it normally acts to regulate gene transcription.8 10 11 C-myc is one of the early response genes, and the mRNA and protein product are increased in cultured cells exposed to mitogens.8 9 In tumours, myc can be activated by translocation in lymphomas or amplification in neuroblastomas. ' (Fig 2) where endogenous RNA is destroyed by pretreatment with micrococcal nuclease; the major translation product was of molecular weight 34 000 with distinct protein bands up to 68 000. Control incubation of this system without the addition of RNA showed no incorporation of [35S]methionine into protein, although unincorporated label was seen in two bands at the gel front (Fig 2) . The translation of distinct proteins from the RNA that has been isolated from biopsies shows that functionally active mRNA is obtained. No difference in the absorption spectrum or improvement in yield was obtained if the biopsies were immediately homogenised in guanidium isothiocyanate rather than being frozen in liquid nitrogen for 12-96 hours before further processing.
EXPRESSION OF C-MYC PROTO-ONCOGENE
To confirm that there was a c-myc mRNA transcript of the expected size in the colonic biopsy RNA preparations, Northern blots were hybridised with an exon 2 c-myc probe. A band of 2-2 kb was seen in RNA extracted from active ulcerative colitis, and (faintly) in normal tissue (Fig 3) .
To quantify c-myc proto-oncogene expression in the small RNA samples available, slot blot hybridisation was used. This had the advantage that 4 Vg RNA samples were sufficient; these were applied to a nitrocellulose filter using a manifold apparatus and hybridised with the Figure 4 . There is an increased ratio of c-myc expression in (left sided) ulcerative colitis compared with normal colonic mucosa taken from the same patient. Parallel replica filters were used to probe with oligo-dT primed cDNA to measure total mRNA applied to each slot; these showed no differences between the colitic and control biopsies (Fig 4) . Similarly, there were no differences in the expression of the constitutive gene r3-actin (Fig 4) . There was also an increased ratio of c-myc expression in segmental Crohn's colitis compared with control colonic mucosa from the same patient, and there were similarly no differences in the amount of overall mRNA or 13-actin expression (Fig 4) . The increased steady state ratio of c-myc expression compared with total mRNA levels is highly significant (p<001) by the Wilcoxon's signed rank test for both ulcerative and Crohn's colitis. These differences do not reflect alterations in c-myc expression at different positions of the colon, because in 11 patients with no macroscopic or histological abnormality there was no difference in c-myc expression in biopsies taken at least 30 cm apart (Fig 5) .
Discussion
This study describes raised c-myc mRNA levels in colonoscopic biopsies from active regions of inflammatory bowel disease compared with inactive regions in the same patient. Extraction of RNA from endoscopic biopsies was used to overcome the problems of rapid RNA degradation encountered with surgical specimens because of the combination of ischaemic injury, high levels of endogenous ribonuclease, and the short halflife ofsome RNA species. This effect is particularly important for mRNA, which only forms 10% of the total RNA preparation32 but is highly labile. 24 As similar levels of c-myc expression are seen in (non-dysplastic) ulcerative colitis and colonic Crohn's disease, it is unlikely that this effect is directly related to the pathogenesis of malignancy. We cannot exclude a further increase in c-myc expression occurring during dysplasia, however; this requires further study. Furthermore, infiltration of the inflamed colon by mononuclear cells may in part be responsible for the raised levels of steady state c-myc mRNA; definition of the cell types of the colonic mucosa involved in raised c-myc expression requires further investigation using in situ hybridisation.
In summary, we have applied a method of RNA extraction to colonoscopic biopsies, which overcomes the problems of degradation and reduced yield encountered with surgical specimens. This technique was convenient because active and inactive colonic mucosa from inflammatory bowel disease could be sampled in the same patient. We have shown increased expression of the labile proto-oncogene c-myc in ulcerative and Crohn's colitis; this overcomes the ambiguity and technical difficulties encountered with immunohistochemical studies. Increased expression of c-myc in inflammatory bowel disease is consistent with its activation in cell cycle control as a result of the inflammatory process
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